Rubenstein M - Search Results

1

BCG in management of superficial bladder cancer.

Guinan P, Crispen R, Rubenstein M. Guinan P, et al. Among authors: rubenstein m. Urology. 1987 Dec;30(6):515-9. doi: 10.1016/0090-4295(87)90428-6. Urology. 1987. PMID: 3318088 Review.

2

Characterization of cellular infiltrates in the rat urinary bladder following BCG and thiotepa intravesical therapy.

Shaw M, McKiel CF, Ray V, Rubenstein M, Guinan P. Shaw M, et al. Among authors: rubenstein m. J Surg Oncol. 1991 Jan;46(1):48-52. doi: 10.1002/jso.2930460112. J Surg Oncol. 1991. PMID: 1824712

3

Tumor infiltrating lymphocytes: the effect of bacillus Calmette Guerin on helper/suppressor-T cell ratios of treated and untreated tumors.

Rubenstein M, Muchnik S, Chet M, Shaw MW, McKiel CF, Guinan PD. Rubenstein M, et al. J Urol. 1991 Dec;146(6):1650-3. doi: 10.1016/s0022-5347(17)38205-8. J Urol. 1991. PMID: 1834865

4

Prostatic ultrasound in follow-up of prostatic disease.

Guinan P, Ray P, Rubenstein M. Guinan P, et al. Among authors: rubenstein m. Urology. 1988 Mar;31(3):275-8. doi: 10.1016/0090-4295(88)90159-8. Urology. 1988. PMID: 2450422

5

BCG in management of transitional cell carcinoma invasive to prostate.

Siami P, Chinn S, Clayton M, Ray V, Rubenstein M, Guinan P. Siami P, et al. Among authors: rubenstein m. Urology. 1989 Dec;34(6):381-2. doi: 10.1016/0090-4295(89)90447-0. Urology. 1989. PMID: 2595884

6

BCG in the management of superficial bladder cancer.

Guinan P, Richardson C, Hanna M, Rubenstein M. Guinan P, et al. Among authors: rubenstein m. Prog Clin Biol Res. 1989;303:447-53. Prog Clin Biol Res. 1989. PMID: 2675002 Clinical Trial.

7

In LNCaP cells enhanced expression of the androgen receptor compensates for Bcl-2 suppression by antisense oligonucleotides.

Rubenstein M, Hollowell CM, Guinan P. Rubenstein M, et al. Ther Adv Urol. 2011 Apr;3(2):51-7. doi: 10.1177/1756287211400493. Ther Adv Urol. 2011. PMID: 21869905 Free PMC article.

8

Increased expression of the androgen receptor with p300 and interleukin-6 coactivators compensate for oligonucleotide suppression of bcl-2: no increased CREB binding protein or interleukin-4 expression.

Rubenstein M, Hollowell CM, Guinan P. Rubenstein M, et al. Ther Adv Urol. 2013 Apr;5(2):85-93. doi: 10.1177/1756287212466281. Ther Adv Urol. 2013. PMID: 23554843 Free PMC article.

9

The effect of BCG on thoracic duct lymphocytes.

Stuhldreher D, Frank W, Shaw M, Muchnik S, Hussein N, Rubenstein M, Guinan P. Stuhldreher D, et al. Among authors: rubenstein m. Immunol Invest. 1992 Dec;21(7):613-21. doi: 10.3109/08820139209069397. Immunol Invest. 1992. PMID: 1487319

10

Effect of BCG upon functional and phenotypic immune markers in rats bearing the Dunning R3327 MAT-LyLu prostatic adenocarcinoma.

Rubenstein M, Shaw MW, Dubin A, McKiel CF, Guinan PD. Rubenstein M, et al. Immunopharmacol Immunotoxicol. 1988;10(4):579-96. doi: 10.3109/08923978809006456. Immunopharmacol Immunotoxicol. 1988. PMID: 2977608

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

254 results

Search Page

Filters